BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6178760)

  • 1. Pharmacokinetics of hydroxyethyl starch in normal subjects.
    Yacobi A; Stoll RG; Sum CY; Lai CM; Gupta SD; Hulse JD
    J Clin Pharmacol; 1982 Apr; 22(4):206-12. PubMed ID: 6178760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagulation.
    Korttila K; Gröhn P; Gordin A; Sundberg S; Salo H; Nissinen E; Mattila MA
    J Clin Pharmacol; 1984 Jul; 24(7):273-82. PubMed ID: 6207208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.
    Mishler JM; Parry ES; Sutherland BA; Bushrod JR
    Br J Clin Pharmacol; 1979 Jun; 7(6):619-22. PubMed ID: 88951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyethyl starch.
    Thompson WL
    Dev Biol Stand; 1980; 48():259-66. PubMed ID: 6168505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery.
    Behne M; Thomas H; Bremerich DH; Lischke V; Asskali F; Förster H
    Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM
    J Clin Apher; 1984; 2(1):52-62. PubMed ID: 6085628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
    Mishler JM
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
    Jungheinrich C; Scharpf R; Wargenau M; Bepperling F; Baron JF
    Anesth Analg; 2002 Sep; 95(3):544-51, table of contents. PubMed ID: 12198032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
    Köhler H; Kirch W; Pitz H
    Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hetastarch: an overview of the colloid and its metabolism.
    Hulse JD; Yacobi A
    Drug Intell Clin Pharm; 1983 May; 17(5):334-41. PubMed ID: 6190620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
    Mishler JM; Dürr HK
    Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroamylasemia induced by hydroxyethyl starch--confirmation by gel filtration analysis of serum and urine.
    Mishler JM; Dürr GH
    Am J Clin Pathol; 1980 Oct; 74(4):387-91. PubMed ID: 6158858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular persistence of hydroxyethyl starch in man.
    Boon JC; Jesch F; Ring J; Messmer K
    Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro.
    Szymanski IO; Teno RA; Gandhi JG; Newburger PE
    Vox Sang; 1984; 47(5):325-9. PubMed ID: 6209854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs.
    Yacobi A; Gibson TP; McEntegart CM; Hulse JD
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):199-204. PubMed ID: 6179136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers.
    Waitzinger J; Bepperling F; Pabst G; Opitz J
    Drugs R D; 2003; 4(3):149-57. PubMed ID: 12757400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial infusion effects of hydroxyethyl starch on ESR, blood typing and crossmatching and serum amylase levels.
    Janes AW; Mishler JM; Lowes B
    Vox Sang; 1977; 32(3):131-4. PubMed ID: 67712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation.
    Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
    Transfusion; 1996 May; 36(5):450-5. PubMed ID: 8693511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.